A mutation in mitochondrial DNA can disrupt the intestine’s frontline defenses long before the effects of aging become visible, according to a study in mice that links defective cellular powerhouses to early-onset intestinal dysfunction during acute colitis. The research, published in Genome Biology, found that animals carrying a high burden of one pathogenic mitochondrial mutation developed poorly differentiated absorptive cells, abnormal Paneth cell granules and a reduced ability to repair the intestinal barrier after injury. The findings provide a detailed view of how mutant mitochondrial genomes behave inside individual intestinal cell types and suggest that the intestine may be especially vulnerable when its rapidly renewing tissues are challenged by inflammation.
Mitochondria are best known as the organelles that generate much of a cell’s energy, but they also regulate metabolism, stress responses, cell death and signaling between tissues. Unlike most of the DNA in a mammalian cell, mitochondrial DNA, or mtDNA, is inherited through the maternal line and exists in many copies within each cell. A cell may therefore contain a mixture of normal and mutant mitochondrial genomes, a condition called heteroplasmy. The proportion of mutant mtDNA can vary from cell to cell and may determine whether a tissue functions normally or crosses a threshold into disease. Mitochondrial disorders often include gastrointestinal symptoms, yet the mechanisms that shape mutant mtDNA levels in the intestine have remained difficult to resolve.
To investigate those mechanisms, Qian Zhang, Xiaoling Deng, Min Jiang and colleagues analyzed two mouse models carrying different mtDNA mutations. The m.G5081A mutation affects a mitochondrial transfer RNA gene, which can interfere with the production of proteins encoded by the mitochondrial genome. The m.G12918A mutation affects a mitochondrial messenger RNA gene and may alter the information used to make a mitochondrial protein. The researchers followed the animals across a two-year lifespan and examined nine subtypes of intestinal epithelial cells, the diverse population of cells that lines the gut. These included intestinal stem cells, mature absorptive enterocytes and secretory Paneth cells, among other epithelial populations.
The team used mitochondrial single-cell assay for transposase-accessible chromatin with sequencing, known as mtscATAC-seq, to track mutation levels while also measuring the regulatory state of individual cells. In this method, a transposase enzyme preferentially cuts and tags regions of DNA that are physically accessible, allowing researchers to infer which genes and control elements are poised for activity. By adapting the approach to mitochondrial genomes, the investigators could examine heteroplasmy at single-cell resolution rather than averaging mtDNA mutations across an entire intestinal tissue. That distinction matters because the gut lining is a mosaic of cell types with different lifespans, energy demands and contributions to barrier maintenance.
Across the intestinal epithelial populations, the researchers observed an age-dependent decline in the abundance of mutant mtDNA. The pattern began in the intestinal stem-cell compartment, suggesting that selection against mutant genomes may be established at the source of epithelial renewal. Intestinal stem cells continuously produce new epithelial cells, which migrate, mature and are eventually shed within days. If stem cells containing more mutant mitochondria are less able to survive, divide or compete with healthier stem cells, the mutant genomes may gradually become less common in the tissue. The study indicates that this process is not confined to a single specialized cell type but is reflected across the epithelial lineage as the animals grow older.
That apparent decline, however, did not mean the mutations were harmless early in life. Young mice with high m.G5081A mutation loads showed profound abnormalities in epithelial function. Single-cell RNA sequencing revealed impaired enterocyte differentiation, meaning that progenitor cells did not efficiently acquire the molecular program required to become fully mature absorptive cells. Enterocytes digest and transport nutrients while helping maintain the physical and biochemical barrier between the intestinal contents and the underlying immune system. Defects in their maturation could therefore affect both nutrient handling and the tissue’s ability to withstand microbial and chemical stress.
The researchers also found defective granule formation in Paneth cells, which occupy the base of intestinal crypts near stem cells. Paneth cells release antimicrobial molecules into the gut and help shape the local environment in which intestinal stem cells operate. Their secretory granules store proteins and other compounds that are discharged in response to microbial cues. Mitochondrial dysfunction could compromise this process by limiting energy production, disturbing protein handling or altering the cellular stress pathways needed for secretion. Abnormal Paneth cell granules may consequently weaken antimicrobial defense while also disrupting signals that support epithelial renewal.
To test whether these cellular defects translated into disease susceptibility, the investigators exposed the mutant mice to dextran sulfate sodium, a chemical widely used to induce acute colitis in experimental animals. DSS damages the intestinal lining, allowing luminal substances to reach deeper tissues and provoke inflammation. In the m.G5081A mice, the intestinal barrier was less able to recover from this injury. The animals’ heightened susceptibility was attributed to mitochondrial dysfunction and impaired barrier restoration, connecting the mutation’s effects on individual epithelial cell programs with the broader course of inflammatory disease. The findings do not show that the mutation causes human colitis, but they identify a plausible biological route by which mitochondrial disease could amplify intestinal injury.
The study’s central message is that mitochondrial mutations can have highly dynamic, cell-specific consequences in the gut. Mutant mtDNA may be progressively selected against as intestinal stem cells age, yet a high mutation burden during an earlier period can already interfere with epithelial differentiation, antimicrobial defense and tissue repair. This timing could help explain why patients with mitochondrial disorders experience gastrointestinal problems that vary widely between individuals and across life stages. It also raises the possibility that intestinal stem-cell fitness, mitochondrial quality control and epithelial regeneration could become targets for future therapies. Any such strategies remain experimental: the work was performed in genetically defined mice, and the researchers emphasize a biological framework rather than a clinical treatment. Still, by combining mitochondrial single-cell profiling with functional tests of colitis, the study offers an unusually close look at how defective cellular energy systems can turn a normally resilient intestinal lining into a vulnerability during inflammation.
